HSIC vs IQV: fair value comparison
Henry Schein, Inc. and IQVIA Holdings Inc. · Updated 2026-09-07
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, IQV currently sits closer to the top of our discount ranking.
| HSIC | IQV | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $89.81 | $267.77 |
| 12-month range | $63.20–$88.52 | $157.77–$258.35 |
| Sector rank | #70 of 113 Healthcare | #69 of 113 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | High |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: HSIC fair value analysis · IQV fair value analysis